SCHEMBL7873579

SCHEMBL7873579

FC(F)(F)CN1CCN=C(c2ccccc2Cl)c2cc(Cl)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 4/20 0.48
NR1I2 O75469 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
OPRM1 P35372 1/20 0.48
PDE4D Q08499 3/20 0.47
ADRA1A P35348 2/20 0.47
GABRA1 P14867 2/20 0.47
GABRG2 P18507 2/20 0.47
GABRB3 P28472 2/20 0.47
GABRA5 P31644 2/20 0.47
GABRA3 P34903 2/20 0.47
GABRA2 P47869 2/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
PTGS2 P35354 1/20 0.47
CHRNA4 P43681 1/20 0.47
SLC6A3 Q01959 1/20 0.47
TP53 P04637 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMARCA2 P51531 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fletazepam SCHEMBL119540 0.91 CYP3A4 (0.48) OPRK1NR1I2ADORA3OPRM1PDE4D
SCHEMBL11531856 0.88 OPRK1 (0.62) OPRK1NR1I2ADORA3OPRM1PDE4D
SCHEMBL11681691 0.81 OPRK1 (0.47) OPRK1NR1I2ADORA3PDE4DADRA1A
SCHEMBL9757526 0.78 OPRK1 (0.59) OPRK1NR1I2ADORA3OPRM1PDE4D
SCHEMBL11680057 0.77 OPRK1 (0.76) OPRK1NR1I2ADORA3PDE4DADRA1A
SCHEMBL7871700 0.77 GABRA1 (0.43) OPRK1NR1I2ADORA3OPRM1PDE4D
SCHEMBL11715519 0.74 GABRA1 (0.50) OPRK1NR1I2ADORA3PDE4DADRA1A
SCHEMBL11681501 0.74 CYP3A4 (0.48) OPRK1NR1I2ADORA3PDE4DADRA1A
SCHEMBL11468031 0.72 OPRK1 (0.48) OPRK1NR1I2ADORA3PDE4DADRA1A
SCHEMBL9848803 0.72 CYP3A4 (0.51) OPRK1NR1I2ADORA3OPRM1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6048857-A TRIFLUOROBENZODIAZEPINE ELLINWOOD JR EVERETT H (US) 2000-04-11 US claimed
EP-0428272-A2 Trifluorobenzodiazepine compounds for use in therapy by intraoral administration Ellinwood, Everett Hews (US) 1991-05-22 EP claimed
US-6313176-B1 SELECTING AN IRREVERSIBLE ENZYME INHIBITOR AS A MEDICAMENT THAT IS METABOLIZED INTO AN UNWANTED OR ADVERSIVE METABOLITE; PLACING IRREVERSIBLE ENZYME INHIBITOR IN A SUITABLE FORMULATION; ADMINISTERING FORMULATION FOR THERAPY ELLINWOOD JR EVERETT J (US) 2001-11-06 US disclosed
US-6140323-A SELECTING DRUG; PLACING FOR INHALATION OR SKIN ADMINISTRATION FORMAULATION; ADMINISTERING FORMULATION SO AS TO BYPASS GASTROINTESTINAL ABSORPTION AND PORTAL VEIN ENTRY TO LIVER TO DECREASE FORMATION OF UNWANTED METABOLITE ELLINWOOD JR EVERETT H (US) 2000-10-31 US disclosed
US-6048857-A TRIFLUOROBENZODIAZEPINE ELLINWOOD JR EVERETT H (US) 2000-04-11 US disclosed